Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Magnetic Stimulation to Treat Prolonged Grief Disorder: A Single-centre, Single-arm, Open-label Phase I/II Proof-of-concept and Feasibility Clinical Trial

NCT06953596 is registered in ClinicalTrials.gov with Bruyère Health Research Institute. as lead sponsor.

NCT NCT06953596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Magnetic Stimulation to Treat Prolonged Grief Disorder: A Single-centre, Single-arm, Open-label Phase I/II Proof-of-concept and Feasibility Clinical Trial
Lead sponsor
Bruyère Health Research Institute.
Phase
Not applicable
Overall status
Recruiting
Start date
November 28, 2025
Completion date
September 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complicated grief, prolonged grief disorder